Gregory Bolan is a Senior Research Analyst covering Healthcare IT and Pharmaceutical Services with Avondale Partners, LLC, a boutique investment banking and asset management firm that is primarily focused on the healthcare and targeted middle market sectors. Over the last decade, he has been honing his skills as a gifted researcher in the financial field and that experience informs every investment decision he makes these days.
His experience as a research analyst is stellar. Before joining Avondale Partners, Gregory was the Managing Director of Healthcare Equity Research with Sterne Agee. Working in that firm’s Nashville office, he focused primarily on pharmaceutical companies. It was there that he was recognized by Starmine as a No. 1 Stock Picker for Life Science Tools & Services. In addition to that honor, which he received in 2014, he was called the “Best Up & Comer” as part of Institutional Investor's All-American Research Team Survey in 2010. Gregory also played a crucial role when it came to building an extremely skilled and knowledgeable team of healthcare analysts to examine such sub-sectors as Specialty Pharma, Managed Care and Medical Devices & Diagnostics.
Gregory Bolan's experience also includes extensive time as a Director of Healthcare Equity Research for the Nashville office of Wells Fargo Securities, as well as stints as a Senior Associate of Healthcare Equity Research with Jefferies & Company in Nashville and as an Associate with a focus in healthcare at FNY GMG Capital, New York. During his time at all of these firms, his primary focus was on the buy side of the healthcare industry.
His experience as a research analyst is stellar. Before joining Avondale Partners, Gregory was the Managing Director of Healthcare Equity Research with Sterne Agee. Working in that firm’s Nashville office, he focused primarily on pharmaceutical companies. It was there that he was recognized by Starmine as a No. 1 Stock Picker for Life Science Tools & Services. In addition to that honor, which he received in 2014, he was called the “Best Up & Comer” as part of Institutional Investor's All-American Research Team Survey in 2010. Gregory also played a crucial role when it came to building an extremely skilled and knowledgeable team of healthcare analysts to examine such sub-sectors as Specialty Pharma, Managed Care and Medical Devices & Diagnostics.
Gregory Bolan's experience also includes extensive time as a Director of Healthcare Equity Research for the Nashville office of Wells Fargo Securities, as well as stints as a Senior Associate of Healthcare Equity Research with Jefferies & Company in Nashville and as an Associate with a focus in healthcare at FNY GMG Capital, New York. During his time at all of these firms, his primary focus was on the buy side of the healthcare industry.
